SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-071273
Filing Date
2024-06-10
Accepted
2024-06-10 16:05:10
Documents
12
Period of Report
2024-06-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hlvx-20240606.htm   iXBRL 8-K 78622
2 EX-3.1 hlvx-ex3_1.htm EX-3.1 13269
  Complete submission text file 0000950170-24-071273.txt   213817

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hlvx-20240606.xsd EX-101.SCH 25790
15 EXTRACTED XBRL INSTANCE DOCUMENT hlvx-20240606_htm.xml XML 4872
Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41365 | Film No.: 241032653
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)